BNET Industries
Last Fiscal Year Sales:$13.4B
- Private
- US
Dow Jones Description
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.
President, Product Development
Susan Desmond-Hellmann MDNumber of Employees 11,186
Contact Information
1 DNA Way
South San Francisco, California 94080-4990
(650) 225-1000
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Roche's Merger Formula for Genentech
-
Curis Reports Third Quarter 2009 Financial Results
-
Genentech's Levinson joins biotech startup's board
-
BUYINS.NET: FFIV, PTV, OSIP, RJF, CFR, DST Expected To Be Higher After Earnings Releases on...
-
Tuesday, Jul 28, 2009
-
Release Archives
-
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Research Collaboration with Genentech South SF DNA
-
Eden Biodesign Selected by Biotecnol SA for cGMP Production of Cardiotrophin-1 for Treatment of...
-
Former Genentech CEO Levinson Quits Google Board
-
PRESS DIGEST - Wall Street Journal - Oct 13
-
SurModics shares surge on $200M Roche pact
-
Genentech inks licensing deal with SurModics
-
SurModics Inc. SRDX Enters Ophthalmic License and Development Agreement with Roche RHHBY and Genentech (South...
-
Singapore sling
-
Roche U.S. cancer drug trial enrollment suspended
News & Analysis
Filter by
genentech inc. and healthcare - All News and Analysis
Genentech Seals Roche's Dominance of Oncology Market
EP Vantage submits: If there was such a thing as a global anti-trust commission they might have something to say about Roche’s (RHHBY.PK) acquisition of Genentech DNA with respect to the Swiss pharma giant’s projected domination of the oncology market; the pharmaceutical industry’s fastest growing and, in three years, biggest...
When Will the Genentech Roller Coaster End?
Mike Huckman submits: On my Thomson Reuters screen on the computer monitor opposite the one I'm using to write this blogpost I have the stock quotes of a few dozen of the biopharma companies I cover. Lately, when I glance over at it, there's been a lot of red....
How Can Both Genentech and Roche Rally?
Mike Huckman submits: How can investors on both sides of the pond be reading this right? The morning after Genentech's DNA big investor meeting shares of the Swiss drugmaker Roche (RHHBY.PK) rebounded in overseas trading and the American Depository Receipts (ADR) that trade over-the-counter here in the States...
Roche Is Considerably Worse Off Without Genentech
Mike Huckman submits: While much to my chagrin Genentech DNA isn't matching Roche's (RHHBY.PK) aggressive media strategy in the ongoing takeover battle, during parts of the biotech company's presentation to analysts and investors today, at least two executives pulled no punches. David Ebersman put up a slide titled,...
Roche-Genentech: $16 Billion Raised, Raptiva Off the Market, Stock Market Doesn't Care
Roche has raised $16 billion from the bond market to fund its takeover of Genentech. It will probably need to pay $40-45 billion to get the company. Roche has about $4.9 billion in cash on its balance sheet, so ... still about $20 billion to go, guys! ...
Roche and Genentech: As the Deal Turns
Mike Huckman submits: What's $23 between friends, er, sparring business partners? The question brings back memories of my grandfather who was of the generation that would hold a grudge for years against a distant relative who still owed him a small amount of money. Anyway, in the ongoing...
Tip for Roche: Use Non-Cash CVRs to Buy Genentech
Thomas Kirchner submits: In an unhappy reminder of January 2008, deals continue to collapse or see reductions in price. After the trouble at Rohm & Haas ROH, the acquisition of Genentech DNA by Roche is another large deal officially on the list of downward revisions in price. On...
Roche Is Still Gunning for Genentech
Mike Huckman submits: Shares of Swiss drugmaker Roche (RHHBY.PK) are trading significantly lower overseas and in over-the-counter activity here in the States after the company reported earnings. But in the U.S., investors are less interested in Roche's numbers and the stock move than they are in what the company...
How Will Genentech Respond to Roche's European Trading Loss?
Sean Butler submits: Shares of Roche Holdings surrendered a tidy sum of 14 Swiss Francs per share in European trading this morning, equivalent to a loss of more than 8.5% of its value. Normally, such a move in shares of Switzerland's largest drug maker would likely be met with little...
Why the Drop in Roche's Genentech Bid?
Mike Huckman submits: Genentech DNA shares dropped three percent Friday or $2.85 to $81.24 after Roche showed some chutzpah and lowered its bid for DNA. Recently, there'd been reports that the Swiss drugmaker, which already has a majority stake in the California biotech, was going to raise the offer...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Susan Desmond-Hellmann MD | President, Product Development |
| David A. Ebersman | Executive Vice President and Chief Financial Officer |
| Hal Barron MD | Chief Medical Officer & Senior Vice President, Development |
| Stephen G. Juelsgaard | Executive Vice President, Secretary and Chief Compliance Officer |
| Ian T. Clark | Executive Vice President, Commercial |
| Patrick Y Yang PhD | Executive Vice President, Product Operations |
| Richard H Scheller PhD | Executive Vice President, Research |
| Marc Tessier-Lavigne | Senior Vice President, Res Drug Discovery |
| Robert Garnick | Senior Vice President, Regulatory, Quality & Compliance |
| Andrew C. Chan | Vice President, Immunology Res |
| Ann L. Lee | Vice President, Process Development |
| Anthony P. Hurley | Vice President, Fill, Finish Manufacturing |
| Ashraf Hanna | Vice President, Alliance Management & Pipeline Strategy Support |
| Charles Calderaro | Vice President, Corp Engineering |
| Charles Johnson | Vice President, Clinical Biotherapeutics |
| Claudia Estrin | Vice President, Decision Support & Commercial Innovation |
| Corsee D. Sanders | Vice President, Biometrics & Business Operations, Medical Affairs |
| David Broad | Vice President & General Manager, Oceanside Product Operations |
| David Schenkein | Vice President, Clinical Hematology & Oncology |
| Denise Smith-Hams | Vice President, HR |
| Francis Jackson | Vice President, Vacaville Prod Operations |
| Gary Harbour | Vice President, Commercial Quality, South San Francisco |
| Genesio Murano | Vice President, Regulatory Affairs |
| Gregory Baird | Vice President, Corp Communications |
| Gwendolyn Fyfe | Vice President, Clinical Hematology & Oncology |
| James P. Miller | Vice President |
| Jennifer E. Cook | Vice President, Marketing Development |
| John M Whiting | Vice President Finance, Treasury and Procurement |
| John Orwin | Vice President |
| John Pinion | Vice President, External Quality |
| Joseph Barta | Vice President, Compliance |
| Joseph S. McCracken | Vice President, Business Development |
| Karen McCormick | Vice President |
| Kenneth Hillan | Vice President, Development Sciences |
| Kent Lieginger | Vice President |
| Kevin McRaith | Vice President |
| Leonard Kanavy | Vice President, Commercial Operations |
| Markus Gemuend | Vice President, Manufacturing Collaborations |
| Martin Babler | Vice President |
| Michael D. Varney | Vice President, Small Molecule Drug Discovery |
| Michael P. Miller | Vice President, Sales & Marketing, HER Family |
| Pamela M. Klein | Vice President, Clinical Oncology |
| Peter Carberry | Vice President, Clinical Operations |
| Philippa Norman | Vice President, Global Supply Chain |
| Quinton C. Oswald | Vice President, Sales & Marketing |
| Richard B Brewer | Vice President, Marketing |
| Ronald C. Branning | Vice President, Quality, Global |
| Roy C. Hardiman | Vice President |
| Scott Carmer | Vice President, Sales & Marketing, Rituxan Immunology |
| Sean A. Johnston | Vice President |
| Timothy L. Moore | Vice President, Manufacturing, South San Francisco |
| Todd Pierce | Vice President, Corp IT |
| Todd Rich | Vice President, Clinical & Commercial Regulatory Affairs |
| Varun Nanda | Vice President |
| Vince Anicetti | Vice President, Prod Portfolio Management |
| Vishva Dixit | Vice President, Molecular Oncology Res |
| W. Robert Arathoon | Vice President, Corp Manufacturing Operations |
| Walter K. Moore | Vice President, Govt Affairs |
| William N. Anderson | Vice President, Sales & Marketing, Immunology |
| Herbert W. Boyer | Co Founder |
| Richard Axel | Co-founder |
| Avi Ashkenazi | Director |
| Dan Eaton | Director |
| Geoff Teeter | Director, Corp Communications |
| Hamilton Mixon | Director, Corp Security Services |
| Henry Lowman | Director, Engineering |
| Kathee Littrell | Director, Investor Relations |
| Lino Gonzalez | Senior Director |
| Lisa Tuomi | Associate Director, Investor Relations |
| Mark Sliwkowski | Director |
| Mary Stutts | Senior Director, Corp Communications |
| Mike Burchmore | Director, Prod Management |
| Nicholas Bruggen | Associate Director |
| Stuart Bunting | Director |
| Wai Wong | Director |
| Brad Failing | Area Manager, Sales, Managed Care |
| D. Searle | Manager, Marketing |
| Diane L. Parks | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care |
| Diane Schrick | Prod Manager, Development |
| Sam Burst | Division Manager, Sales |
| Robert Andreatta | Controller |
| Amos Smith | Consultant |
| Beni Wolf | |
| Bradley Wolk | Engr, Process Development |
| Chung Hsu | Engr, Process Development |
| Colin Watanabe | Programmer Analyst, Corp IT |
| Dorothy French | |
| Fred Cohen | |
| Janet Rossant | |
| Jonathan K.C. Knowles | Head, Global Research |
| Joseph L Goldstein | |
| Michael S Brown | |
| Napoleone Ferrara | |
| Nicholas van | |
| Paul Godowski | |
| Richard O Hynes | |
| Robert van Reis | Engr, Process Development |
| Wai Lee | |
| William Wood | |
| Charles A. Sanders | Director |
| Grant Heidrich | investor |
| Norman Fogelsong | Venture Investor |
| Susan Desmond | member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Debra L. Reed | Board of Directors |
| Erich Hunziker | Board of Directors |
| William M. Burns | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | President, Product Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President and Chief Financial Officer | Current |
| Aquaya | Executive Vice President and Chief Financial Officer | Current |
| Intarcia Therapeutics, Inc. | Director | Current |
| Oppenheimer & Co. Inc. | research analyst | Former |
| Brown University | Bachelor of Arts in Economics and International Relations | Former |
| Genentech, Inc. | member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Chief Medical Officer & Senior Vice President, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Secretary and Chief Compliance Officer | Current |
| Wilson Sonsini Goodrich & Rosati | associate | Former |
| Iowa State University | Master of Science degree | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech Foundation | Executive Vice President, Commercial Operations | Current |
| Genentech, Inc. | Executive Vice President, Commercial | Current |
| Vernalis plc | Board of Directors | Current |
| Genentech Foundation | General Manager | Former |
| Pharmacia Corporation | Former | |
| Southampton University | Bachelor of Science Degree In Biological Sciences | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Product Operations | Current |
| Merck & Co. Inc. | Former | |
| The Ohio State University | doctorate in electrical engineering and computer science | Former |
| University of Cincinnati | Master of Science in electrical engineering | Former |
| National Chiao Tung University | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Research | Current |
| Genentech Foundation | Executive Vice President, Research | Current |
| National Academy of Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Member | Current |
| National Academy of Sciences | Member | Current |
| Genentech Foundation | Senior Vice President, Research | Former |
| California Institute of Technology | doctorate | Former |
| University of Wisconsin | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Res Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Regulatory, Quality & Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Immunology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Fill, Finish Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Alliance Management & Pipeline Strategy Support | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Engineering | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Biotherapeutics | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Decision Support & Commercial Innovation | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Biometrics & Business Operations, Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President & General Manager, Oceanside Product Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Vacaville Prod Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Commercial Quality, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Marketing Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President Finance, Treasury and Procurement | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, External Quality | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Development Sciences | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing Collaborations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Small Molecule Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, HER Family | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Global Supply Chain | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Agensys, Inc. | President and CEO of Arca Discovery | Current |
| ARCA Discovery, Inc. | President and Chief Executive Officer | Current |
| Genentech, Inc. | Vice President, Marketing | Current |
| Crest Asset Management, Inc. | Partner | Current |
| Anesiva Inc. | Board of Directors | Current |
| Corus Pharma, Inc. | Board of Directors | Current |
| Agensys, Inc. | Board of Directors | Current |
| SRI International | Director | Current |
| ARCA Discovery, Inc. | Board of Directors | Current |
| Scios Inc. | Chief Executive Officer | Former |
| Scios, Inc. | CEO | Former |
| Scios Inc. | President | Former |
| Scios, Inc. | President | Former |
| Heartport, Inc. | Coo | Former |
| Johnson & Johnson | COO of Heartport | Former |
| Dendreon Corporation | Chairman | Former |
| American Heart Association, Inc. | chairman | Former |
| Dendreon Corporation | Board of Directors | Former |
| Northwestern University | M.B.A. | Former |
| Virginia Polytechnic Institute and State University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Quality, Global | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Rituxan Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical & Commercial Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Prod Portfolio Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Molecular Oncology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Manufacturing Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Govt Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co Founder | Current |
| University of California, San Francisco | Professor of Biochemistry | Current |
| Genentech, Inc. | Board of Directors | Current |
| Allergan, Inc. | Vice Chairman | Current |
| National Academy of Sciences | Board of Directors | Current |
| Allergan, Inc. | Board of Directors | Former |
| National Academy of Sciences | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co-founder | Current |
| Columbia University | University Professor, Investigator | Former |
| University of California, San Francisco | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Security Services | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Engineering | Current |
| The Johns Hopkins University | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Prod Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Area Manager, Sales, Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Prod Manager, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Division Manager, Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Columbia University | Visiting Professor | Current |
| Cambridge University | Visiting Professor | Current |
| Red Abbey, LLC | Senior Advisor | Current |
| Genentech, Inc. | Consultant | Current |
| Auckland University | Visiting Professor | Current |
| Incyte Corporation | Consultant | Current |
| University of Pennsylvania | Professor | Current |
| Merck & Co. Inc. | Consultant | Current |
| University of Pennsylvania | Chairman | Current |
| Kosan Biosciences, Inc. | Board Advisor | Current |
| Dihedron Corp | Board Advisor | Current |
| Pharmacopeia Drug Discovery Inc. | Board Advisor | Current |
| Provid Pharmaceuticals, Inc. | Board of Directors | Current |
| Monell Chemical Senses Center | Member | Current |
| The Rockefeller University | Research Associate | Former |
| The Rockefeller University | Ph.D. | Former |
| Bucknell University | M.S. Degrees | Former |
| Bucknell University | B.S. | Former |
| The Rockefeller University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Programmer Analyst, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current | |
| Washington State University | Scientist | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | Managing Director, Global Pharmaceutical Research | Current |
| Genentech, Inc. | Head, Global Research | Current |
| Genentech, Inc. | Board of Directors | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| University of East Anglia | Honours Degree in Molecular Genetics | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current | |
| University of California, San Francisco | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| The University of North Carolina | Trustee | Current |
| marketRx Inc. | Current | |
| Feinstein Kean Healthcare | Current | |
| Vertex Pharmaceuticals Incorporated | Chairman of the Board | Current |
| Venrock Associates | Chairman of the Board of Directors | Current |
| Foundation for the National Institutes of Health | Chairman, Executive Committee | Current |
| Icagen, Inc. | Chairman | Current |
| Project Hope | Chairman | Former |
| Drug Safety Alliance, Inc. | Board of Directors | Current |
| Icagen, Inc. | Board of Directors | Current |
| Kendle International Inc. | Director | Current |
| Cephalon, Inc. | Board of Directors | Current |
| Genentech, Inc. | Director | Current |
| Pharmacopeia Drug Discovery Inc. | Board of Directors | Current |
| Radius Ventures, LLC | Board of Directors | Current |
| Csis Inc | Board of Directors | Current |
| Cardioxyl Pharmaceuticals, Inc. | Board of Directors | Current |
| Trimeris, Inc. | Director | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Epiphany Biosciences, Inc. | Board of Directors | Current |
| Staffmark | Board of Directors | Current |
| Scios, Inc. | Director | Current |
| Reata Pharmaceuticals, Inc | Board of Directors | Current |
| Vrtx | Board of Directors | Current |
| Science & Technology Group | CEO | Former |
| Massachusetts General Hospital | General Director | Former |
| Harvard Medical School | director of Massachusetts General Hospital | Former |
| Massachusetts Gen Hospital | General Director | Former |
| Harvard Medical School | Professor of Medicine | Former |
| Meredith College | trustee | Former |
| Scios Inc. | Former | |
| New York Academy of Sciences | Chairman | Former |
| Vertex Pharmaceuticals Incorporated | Board of Directors | Current |
| Genaera Corporation | Board of Directors | Former |
| Reynolds Metals, Inc. | Board of Directors | Former |
| Squibb Corporation | Board Member | Former |
| Biopure Corporation | Director | Former |
| Massachusetts General Hospital | Director | Former |
| Squibb Corporation | Vice Chairman | Former |
| The University of Texas Southwestern Medical School | M.D. | Former |
| The University of Texas | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | CFO | Current |
| F. Hoffmann-La Roche Ltd. | CFO | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| Genentech, Inc. | Board of Directors | Current |
| Holcim Ltd. | Board of Directors | Current |
| Diethelm Keller Holding Ltd. | Chief Executive Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Mayfield Fund | Partner Emeritus | Current |
| Prospect Venture Partners | Advisor | Current |
| Ngm Biopharmaceuticals, Inc. | Board of Directors | Current |
| DoveBid, Inc. | Director | Current |
| Cytokinetics, Inc. | Board of Directors | Current |
| Genentech, Inc. | investor | Current |
| Cytokinetics, Inc. | investor | Current |
| MIPS Technologies, Inc. | investor | Current |
| Immunex Corporation | investor | Current |
| DoveBid, Inc. | investor | Current |
| SGI Inc. | investor | Current |
| Amgen Inc. | investor | Current |
| Tularik, Inc. | investor | Current |
| Millennium Pharmaceuticals, Inc. | investor | Current |
| Western Association of Venture Capitalists | President | Former |
| Aveo Pharmaceuticals, Inc. | Former | |
| Mayfield | Former | |
| Tularik, Inc. | Chairman of the Board | Former |
| Millennium Pharmaceuticals, Inc. | Board of Directors | Former |
| Columbia University | MBA | Former |
| Stanford University | BA | Former |
| Organization | Position | Status |
|---|---|---|
| International Venture Partners, Inc. | General Partner | Current |
| Cortina Systems Corporation | Board of Directors | Current |
| Genentech, Inc. | Venture Investor | Current |
| Verisity, Ltd. | Venture Investor | Current |
| Aspect Software, Inc. | Investor | Current |
| 3Com Corporation | Venture Investor | Current |
| Cypress Semiconductor Corporation | Venture Investor | Current |
| Silicon Graphics, Inc. | Venture Investor | Current |
| Artisan Components, Inc. | Investor | Current |
| WebEx Communications, Inc. | Venture Investor | Current |
| MIPS Technologies, Inc. | Venture Investor | Current |
| LSI Corporation | Venture Investor | Current |
| Applied Biosystems Group | Venture Investor | Current |
| Dust Networks | Venture Investor | Current |
| Linear Technology Corp. | Venture Investor | Current |
| SupportSoft, Inc. | Venture Investor | Current |
| Concur Technologies, Inc. | Investor | Current |
| Compaq Computers | Investor | Current |
| Websense Inc. | Investor | Current |
| Lam Research Corporation | Investor | Current |
| Polycom, Inc. | Investor | Current |
| Motion Computing, Inc. | Investor | Current |
| @Road, Inc. | Venture Investor | Current |
| Amgen Inc. | Venture Investor | Current |
| Quantum Corporation | Venture Investor | Current |
| Digital River, Inc. | Venture Investor | Current |
| Institutional Venture Partners | General Partner | Former |
| Hewlett-Packard Company | computer programmer | Former |
| McKinsey & Company, Inc. | management consultant | Former |
| Stanford University | Board Member | Former |
| Harvard Law School | J.D | Former |
| Harvard Business School | M.B.A | Former |
| Stanford University | B.S. degree in Management Science & Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | member | Current |
| The University of California, San Francisco | Assistant Professor | Former |
| University of California, Berkeley | Master of Science degree in Epidemiology and Biostatistics | Former |
| University of Nevada | Bachelor of Science in Pre-Medicine and her Medical Degree | Former |
| University of California, San Francisco | adjunct associate professor of Epidemiology and Biostatistics | Former |
Executive News
-
Genentech names Clark as CEO:
-
Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes; More...
-
Roche Names Pharma Chief
-
Genentech names new CEO
-
Genentech names new CEO
-
Roche Announces New Corporate Executive Committee
-
Roche moving Clark to CEO of Genentech
-
Severin Schwan finds his feet as Roche CEO
-
Facebook Reaps Recruits at High Levels
-
Facebook’s Zuck is on a personal mission — may expand staff 50 percent this year
-
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


